Carer's Week

Views & Analysis

There are an estimated nine million carers in the UK, and their contributions to society, individually and as a group, are unparalleled.

News

argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.